Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting-Reference-Cited by-同舟云学术

Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting

Published:2017-06 Issue:1 Volume:525 Page:139-148
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Fernández-García Raquel,de Pablo Esther,Ballesteros María Paloma,Serrano Dolores R.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity;Adams;Biomacromolecules,2003

2. Comparison between liposomal formulations of amphotericin B;Adler-Moore;Med. Mycol.,2016

3. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing;Alhijjaj;Eur. J. Pharm. Biopharm.,2016

4. Antifungal agents for the treatment of systemic fungal infections in children. Canadian Paediatric Society;Allen;Infect. Dis. Immun. Committee,2010

5. Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis;Amaral;J. Antimicrob. Chemother.,2009

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transferosomes as innovative drug delivery systems for enhanced antifungal therapy: A comprehensive review;Journal of Drug Delivery Science and Technology;2024-05

2. Amphotericin B in the Era of New Antifungals: Where Will It Stand?;Journal of Fungi;2024-04-10

3. Advances in nanotechnology for improving the targeted delivery and activity of amphotericin B (2011–2023): a systematic review;Nanotoxicology;2024-04-02

4. Potential Activity of Micafungin and Amphotericin B Co-Encapsulated in Nanoemulsion against Systemic Candida auris Infection in a Mice Model;Journal of Fungi;2024-03-27

5. Developing nanosize carrier systems for Amphotericin‐B: A review on the biomedical application of nanoparticles for the treatment of leishmaniasis and fungal infections;Biotechnology Journal;2023-12-15